Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®
Ferdinand Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A RomijnDepartment of Endocrinology and Metabolism, Leiden University Medical Center, Leiden, The NetherlandsBackground: In acromegaly, expert surgery is curative in only about 60% of patients. Postoperative radiation therapy is ass...
Guardado en:
Autores principales: | Ferdin, Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e129be341b1540a8bdfabf329e5c5f9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica G, et al.
Publicado: (2020) -
Updates on the use of ureteral stents: focus on the Resonance® stent
por: Thomas MT Turk, et al.
Publicado: (2010) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008) -
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
por: Nanda K, et al.
Publicado: (2012) -
New treatment options in the management of IBD – focus on colony stimulating factors
por: Josué Barahona-Garrido, et al.
Publicado: (2008)